Lisanti Capital Growth LLC acquired a new position in RA Medical Systems Inc (NYSE:RMED) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 59,235 shares of the company’s stock, valued at approximately $1,078,000. Lisanti Capital Growth LLC owned 0.49% of RA Medical Systems at the end of the most recent reporting period.
Separately, Rockefeller Capital Management L.P. acquired a new position in shares of RA Medical Systems in the third quarter worth approximately $120,000.
Shares of RMED opened at $8.91 on Friday. RA Medical Systems Inc has a 52-week low of $8.29 and a 52-week high of $22.00.
A number of equities analysts recently commented on RMED shares. SunTrust Banks started coverage on RA Medical Systems in a research note on Monday, October 22nd. They issued a “buy” rating and a $16.00 price objective on the stock. Maxim Group started coverage on RA Medical Systems in a research note on Friday, November 2nd. They issued a “buy” rating and a $23.00 price objective on the stock. Piper Jaffray Companies started coverage on RA Medical Systems in a research note on Monday, October 22nd. They issued an “overweight” rating and a $23.00 price objective on the stock. Finally, Cantor Fitzgerald started coverage on RA Medical Systems in a research note on Monday, October 22nd. They issued an “overweight” rating and a $21.00 price objective on the stock.
COPYRIGHT VIOLATION WARNING: “Lisanti Capital Growth LLC Takes $1.08 Million Position in RA Medical Systems Inc (RMED)” was reported by American Banking News and is the property of of American Banking News. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/11/10/lisanti-capital-growth-llc-takes-1-08-million-position-in-ra-medical-systems-inc-rmed.html.
RA Medical Systems Profile
Ra Medical Systems, Inc, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.
Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.